Experian reported H1 FY17 results in line with our estimates. Lfl sales increased by 5% (Q2 FY17: +5%, Q1 FY17: +5%, FY16: +5%; our estimate: +5.2%), largely driven by credit services (+7% yoy; new client wins in US hospitals) and the decision analytics business (+8% yoy; higher demand of fraud and identity management software). North America’s organic revenue was up 5% (vs Q1 FY17: +5%, FY16: +3%; our estimate: +5.8%), once again driven by strong credit services demand from the health
23 Dec 2016
Fundamentals remain strong; limited upside in the near term
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Fundamentals remain strong; limited upside in the near term
Experian PLC (EXPN:LON) | 3,280 229.6 0.2% | Mkt Cap: 30,121m
- Published:
23 Dec 2016 -
Author:
Nishant Choudhary -
Pages:
3
Experian reported H1 FY17 results in line with our estimates. Lfl sales increased by 5% (Q2 FY17: +5%, Q1 FY17: +5%, FY16: +5%; our estimate: +5.2%), largely driven by credit services (+7% yoy; new client wins in US hospitals) and the decision analytics business (+8% yoy; higher demand of fraud and identity management software). North America’s organic revenue was up 5% (vs Q1 FY17: +5%, FY16: +3%; our estimate: +5.8%), once again driven by strong credit services demand from the health